Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | ERN1 | O75460 | 5/20 | 0.46 |
| ▸ | TLR2 | O60603 | 1/20 | 0.46 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.46 |
| ▸ | TLR6 | Q9Y2C9 | 1/20 | 0.46 |
| ▸ | PRKDC | P78527 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | SRC | P12931 | 1/20 | 0.42 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.41 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.41 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29953692 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRKDM4ETDP1ERN1 | |
| SCHEMBL1846692 | 0.88 | ALDH1A1 (0.48) | ALDH1A1TSHRKDM4ETDP1ERN1 | |
| SCHEMBL10541475 | 0.88 | ALDH1A1 (0.48) | ALDH1A1TSHRKDM4ETDP1ERN1 | |
| SCHEMBL7819525 | 0.83 | ERN1 (0.46) | ALDH1A1TSHRKDM4ETDP1ERN1 | |
| SCHEMBL12816057 | 0.83 | ALDH1A1 (0.40) | ALDH1A1TSHRKDM4ETDP1ERN1 | |
| SCHEMBL29818683 | 0.83 | ALDH1A1 (0.48) | ALDH1A1TSHRKDM4ETDP1ERN1 | |
| SCHEMBL29954368 | 0.83 | ERN1 (0.66) | ALDH1A1TSHRKDM4ETDP1ERN1 | |
| SCHEMBL738533 | 0.83 | ERN1 (0.66) | ALDH1A1TSHRKDM4ETDP1ERN1 | |
| SCHEMBL13605931 | 0.82 | ERN1 (0.59) | ALDH1A1ERN1TLR2TLR1TLR6 | |
| SCHEMBL6202266 | 0.82 | ALDH1A1 (0.47) | ALDH1A1TSHRKDM4ETDP1ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090076168-A1 | AMINE-BASED AND IMINE-BASED POLYMERS, USES AND PREPARATION THEREOF | LE TIEN CANH | 2009-03-19 | — | — | US | claimed |
| WO-2006092057-A1 | AMINE-BASED AND IMINE-BASED POLYMERS, USES AND PREPARATION THEREOF | LABORATOIRES MAUVES INC. (CA) | 2006-09-08 | — | — | WO | claimed |
| US-20060084176-A1 | Detection of uronium salts | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2006-04-20 | — | — | US | claimed |
| EP-4720038-A1 | (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES | Neophore Limited (GB) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024246496-A1 | (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES | Neophore Limited (GB) | 2024-12-05 | — | — | WO | disclosed |
| CN-115583899-B | Preparation method of quantum dot catalytic amino butyronitrile compound | 浙江理工大学 | 2023-11-21 | — | — | CN | disclosed |
| CN-115583899-A | Preparation method of quantum dot catalyzed aminobutyronitrile compound | 浙江理工大学 | 2023-01-10 | — | — | CN | disclosed |
| US-20210238170-A1 | 5,5-Difluoro- and 5-Fluoro-5-Methyl-C-Glycoside Derivatives Useful As Dual SGLT1 / SGLT2 Modulators | JANSSEN PHARMACEUTICA NV (BE) | 2021-08-05 | — | — | US | disclosed |
| EP-2968258-B1 | DUAL SGLT1/SGLT2 INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2020-02-12 | — | — | EP | disclosed |
| WO-2019215633-A1 | 5,5-DIFLUORO- AND 5-FLUORO-5-METHYL-C-GLYCOSIDE DERIVATIVES USEFUL AS DUAL SGLT1 / SGLT2 MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2019-11-14 | — | — | WO | disclosed |
| EP-2914580-B1 | THIOARYL DERIVATIVES AS GPR120 AGONISTS | LG CHEMICAL LTD (KR) | 2019-02-20 | — | — | EP | disclosed |
| US-4619945-A | Polyene compounds useful in the treatment of allergic responses | USV PHARMACEUTICAL CORP (US) | 1986-10-28 | — | — | US | disclosed |
| EP-0128006-A2 | A soil-disease-controlling agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-12-12 | — | — | EP | disclosed |
| US-4446284-A | Method for preparing a polymer containing pendant unsaturation | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1984-05-01 | — | — | US | disclosed |
| US-4444567-A | ALKOXY BENZALDEHYDES, ALKOXY BENZOATES | PHILLIPS PETROLEUM COMPANY (US) | 1984-04-24 | — | — | US | disclosed |
| US-4197309-A | AND THEIR OXIMES, USED TO INDUCE URICOSIC EFFECT WITHOUT DIURESIS | ALBERT ROLAND S.A. (FR) | 1980-04-08 | — | — | US | disclosed |
| US-4128648-A | ANTIINFLAMMATORY | E. R. SQUIBB & SONS, INC. (US) | 1978-12-05 | — | — | US | disclosed |
| US-4002616-A | POLYESTERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-01-11 | — | — | US | disclosed |
| US-3962220-A | ONE-STEP, AROMATIC ALDEHYDES, ACETIC ACID | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3962221-A | CONDENSATION, REDUCTION, OXIDATION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210238170-A1 | 5,5-Difluoro- and 5-Fluoro-5-Methyl-C-Glycoside Derivatives Useful As Dual SGLT1 / SGLT2 Modulators | SLC5A2, SLC5A1, SLC2A4 | ALDH1A1 1070/4885TSHR 3226/4885KDM4E 1469/4885 |
| US-20090076168-A1 | AMINE-BASED AND IMINE-BASED POLYMERS, USES AND PREPARATION THEREOF | SMS, INMT, SRM | ALDH1A1 117/4885TSHR 3263/4885KDM4E 1007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.